
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares For Multiple Phase ...
(MENAFN- Investor Brand Network) NanoViricides, Inc. (NYSE American: NNVC) filed its Q1 2025 report and announced progress on NV-387, its broad-spectrum antiviral drug candidate. The company has received clearance from the DRC's National Ethics …